Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.